DETERMINATION OF ANTI-CANCER DRUG PALBOCICLIB FROM HUMAN BIOLOGICAL FLUIDS BY USING DIFFERENTIAL PULSE VOLTAMMETRIC METHOD AT BORON DOPED DIAMOND ELECTRODE

Objective: A very efficient and sensitive electrochemical technique utilizing differential pulse voltammetry (DPV) at a boron-doped diamond electrode (BDDE) was devised to measure Palbociclib in this study. Material and Method: All experiments employed typical three-electrode cell of 10 ml capacity in conjunction with boron-doped diamond electrode, a platinum wire counter electrode, and an Ag/AgCl reference electrode. During electrochemical measurements, DPV and cyclic voltammetry (CV) methods was utilized at BDDE. Result and Discussion: Based on experimental findings from electrochemical characterization investigations, it was determined that oxidation behavior of Palbociclib in BDDE is irreversible and regulated by diffusion. Anodic peak current exhibited a linear relationship within concentration range of 0.01–1 µM, 0.02–0.8 µM, and 0.02–0.8 µM in pH 2.0 phosphate buffer solution (PBS) for reference substance solution, human serum, and urine samples, respectively. Limits of detection were found as 2.28 nM, 2.93 nM, and 1.31 nM for standard drug solution, human serum and urine samples, respectively. In order to validate the developed method, its repeatability, reproducibility, selectivity, precision and accuracy in all environments were investigated and calculated. This method was successfully applied for the analysis of Palbociclib in human serum and urine samples .